erlotinib
Erlotinib
ERK1 as a Therapeutic Target for Dendritic Cell Vaccination against
ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors
Eric Van Cutsem, UZ Leuven
Eric K. Rowinsky, MD
Eribulin Mesylate: A New Therapeutic Option for Metastatic Breast
Eribulin for treating locally advanced or metastatic breast cancer
ERG protein expression reflects hormonal treatment response and is
ERG AND SIM2 TRANSCRIPTION FACTORS IN CARCINOGENESIS AND POTENTIAL CLINICAL UTILITY
Erectile function, incontinence, and other quality of life outcomes
Erectile Dysfunction
ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and
ERCC1 mRNA Expression by KRAS Mutation Status in Colorectal
ERC/mesothelin is expressed in human gastric cancer tissues and
ErbB4 increases the proliferation potential of human lung cancer
ErbB/HER protein-tyrosine kinases: Structures and small molecule
ErbB-3 Predicts Survival in Ovarian Cancer
Eradication of Leukemia Stem Cells as a New Goal of Therapy in
Era of molecular targeted therapy for lung cancer: The
